MAIA Biotechnology, Inc.
MAIA· NYSE
Released Aug 10, 2026, before the open
10-Q filed Aug 10, 2026, 41 days after period end · 0001493152-26-036764
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$7.94M | -$5.35M | -$8.88M | -$4.52M |
| EPS Diluted | -$0.13 | -$0.18 | -$0.40 | -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MAIA Biotechnology, Inc. · CIK 1878313 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end
2.1% from the close of Aug 7, 2026 to the close of Aug 10, 2026, the first after the release.